ReviewFrontiers in neurology2025

Phase-targeted erythropoietin derivatives for traumatic brain injury: bridging mechanisms to precision therapy.

Yujin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.